Pre-Diagnosis Observational and Prescription History associated with Alzheimer's Disease Incidence
Williams, G.
Show abstract
BackgroundAlzheimers disease (AD) has so far proved refractory to intervention. However, disease incidence is variable across prior medication and observational measures. The present study adopted a data-driven approach to inform possible drug repurposing strategies in the light of concurrent prescription and biometric data. Methods and ResultsA real-world dataset was harnessed to compare observational and prescription data for 250,000 individuals prior to AD diagnosis against an age-, sex-, and clinical practice-matched control cohort with no AD history. Observation data was shown to both explain the associations of classes of drug prescription with AD incidence and to bolster the repurposing potential of the GLP-1 agonist class of anti-diabetic drugs. ConclusionThis study provides insights into how drug repurposing based on prescription histories can be informed by concurrent observational data. These findings offer novel insights to be explored in future research on causal models for AD progression.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Impact of different diagnostic measures on drug class association with dementia progression risk: a longitudinal prospective cohort study 94%
- Alzheimer's disease susceptibility gene apolipoprotein e (APOE) and blood biomarkers in UK Biobank (N=395,769). 92%
- Exenatide reverts the high-fat-diet-induced impairment of BDNF signaling and inflammatory response in an animal model of Alzheimer’s disease 92%
Similar papers in this journal
- Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone 92%
- Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer’s disease and progressive supranuclear palsy 92%
- Social isolation is linked to classical risk factors of Alzheimer's disease-related dementias 92%
Similar papers in this journal
- Association between anticholinergic burden and dementia in UK Biobank 94%
- AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discovery 92%
- A metabolite-based machine learning approach to diagnose Alzheimer's-type dementia in blood: Results from the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort 92%
Similar papers in this journal
- The Incidence of Immune Mediated Inflammatory Diseases Following COVID-19: a Matched Cohort Study in UK Primary Care 89%
- Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood 88%
- Maternal smoking during pregnancy and type 1 diabetes in the offspring: A nationwide register-based study with family-based designs 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.